EUS-DFI in Solid Pancreatic Lesions
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJulio Iglesias García
About this trial
This prospective, international, multicenter observational study aims to evaluate the role of Endoscopic Ultrasound-guided Detective Flow Imaging (EUS-DFI) in the characterization of solid pancreatic lesions. The study will assess microvascularization patterns identified by EUS-DFI and their association with the final diagnosis, using histopathology or clinical follow-up as the reference standard. Secondary objectives include evaluating interobserver agreement and the diagnostic accuracy of DFI vascular patterns for differentiating benign and malignant pancreatic lesions.
Eligibility criteria
Qualifiers
Adults aged 18 years or older.
Presence of a solid pancreatic lesion identified during endoscopic ultrasound (EUS), regardless of the indication for the examination.
Ability and willingness to provide written informed consent.
Disqualifiers
Predominantly cystic pancreatic lesions.
Anatomical abnormalities preventing adequate EUS examination.
Limited ability to understand the study procedures or provide informed consent.
Refusal to sign the informed consent form.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Julio Iglesias García
Lead sponsor
Hospital Clinico Universitario de Santiago
Sponsor institution
Ospedale San Raffaele, Università Vita Salute San Raffaele
Collaborator
Policlinico Universitario Campus Bio-Medico
Collaborator
Leids Universitair Medisch Centrum (LUMC), Leiden
Collaborator
Source ClinicalTrials.gov